Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Parkinson's disease

Tracking the variability of phenotypes

    • Congress Reports
    • Neurology
    • RX
    • Studies
  • 2 minute read

Whereas earlier disease concepts assumed that patients with PD would follow a rather uniform clinical course within their disease entities (PD, PSP, CBD, MSA), more recent cohort data show that clinical phenotypes and disease courses actually vary widely within disease entities. What does this mean in practice?

To date, Parkinson’s disease is a clinical diagnosis based exclusively on motor symptoms. Classification is made with regard to symptoms such as akinesia, rigor, tremor, and dyskinesias, among others. However, nonmotor symptoms do not occur only in the prodromal stage. Olfactory disturbances, constipation, sleep disturbances or depression may become apparent throughout the course of the disease. Their breadth and variability therefore often determine the phenotype and variability, reported Prof. Claudia Trenkwalder, MD, Kassel, Germany (D). Studies in a prospective Parkinson’s cohort showed significant progression in both motor function and cognition after only four years. In parallel, predictive factors could be observed. These include, for example, coronary heart disease, hypertension and uric acid. “Therefore, we should keep in mind that comorbid conditions also have an impact on the variability of phenotypes,” she said. Patients who develop REM sleep disorder during or before PD are characterized by more significant cognitive deficits.

Analyze atypical courses more precisely as well

Similar developments can also be observed in atypical Parkinson’s syndromes. These include the synucleinopathies with multisystem atrophy (MSA) and Lewy body disease (LKK), and the tauopathies with progressive supra-nuclear palsy (PSP) and corticobasal degeneration (CBD). Cardinal symptoms of PSP include reduced cognition with fluctuating attention and wakefulness, visual hallucinations with detailed elaboration, REM sleep behavior disorder, and bradykinesia, resting tremor, and/or rigor. An early marker in patients with REM sleep disorder, which is a high risk for developing PD or PSP, is positive RT-QuIC. In the future, MSA will be divided into clinically established MSA and clinically probable MSA. For akinesia, a correlation with putaminal and nigral degeneration could be detected. The decreased responsiveness to L-dopa typical in advanced stages of MSA may be due to a loss of D1- and D2-like dopamine receptors.

Decoding the chameleon

PSP can be divided into different phenotypes based on neuropathological findings. “By characterizing the types in this way, many more patients can now be diagnosed with PSP,” the expert emphasized. In addition to the typical Richardson syndrome (PSP-RS), for example, PSP presents with progressive gait freezing (PSP-PGF), predominant parkinsonism (PSP-P), presominant frontal presentation (PSP-F), or predominant ocular motor dysfunction (PSP-OM). PSP-RS occurs most frequently at 24%, followed by PSP-P at 19% and PSP-F at 18%. Among the most difficult diagnostic classifications is CBD, whose phenotyping followed retrospective classification based on neuropathological studies. Corticobasal syndrome meets current CBD criteria, then frontal syndrome, nonfluent/agrammatic variant of primary progressive aphasia, and PSP syndrome. CBD is also known as the chameleon of Parkinson’s syndromes, which is why attention to the different phenotypes is particularly important. A diagnosis of CBD should also always be considered for aphasic syndromes, Trenkwalder recommended.

Source: ‘Variability in phenotype and progression in Parkinson’s syndromes: neurobiological causes and therapeutic options’, Presidential Symposium, 24 Mar 2022. (German Congress on Parkinson’s Disease and Movement Disorders)

 

InFo NEUROLOGY & PSYCHIATRY 2022; 20(2): 30.

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • Cohort data
  • Dopamine
  • L-Dopa
  • Parkinson's
  • Parkinson's disease
  • Phenotypes
Previous Article
  • Telemedicine

Teledermatology in practice

  • CME continuing education
  • Dermatology and venereology
  • Education
  • General Internal Medicine
  • Prevention and health care
  • RX
  • Studies
View Post
Next Article
  • Immuno-oncology

Immune checkpoint inhibitors in carcinoma patients – update for the primary care physician.

  • Congress Reports
  • General Internal Medicine
  • Oncology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Cannabis - medical vs. non-medical use

Interim assessment: the boundaries are fluid

    • Cases
    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Phytotherapy
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Case Report

Cutaneous myiasis caused by botfly larvae

    • Cases
    • Dermatology and venereology
    • Education
    • General Internal Medicine
    • Infectiology
    • RX
    • Tropical and travel medicine
View Post
  • 6 min
  • Chronic insomnia, REM sleep instability and emotional dysregulation

Risk factors for anxiety and depression

    • Education
    • General Internal Medicine
    • Neurology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Immune sensors

Dysfunctional signaling pathways in cardiomyocytes and their role in heart disease

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 0 min
  • Inoperable NSCLC

Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
View Post
  • 9 min
  • Dementia

Recognize incipient progression and identify countermeasures

    • Congress Reports
    • General Internal Medicine
    • Geriatrics
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Subtype-specific risks and implications for neurological care

Suicidal tendencies in dementia

    • Education
    • Geriatrics
    • Neurology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Study report: Hidradenitis suppurativa

Comparison of rifampicin monotherapy with clindamycin/rifampicin combination

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Infectiology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    PH and lung diseases
  • 2
    Treatment of comorbidities in older people
  • 3
    Multidisciplinary teams in oncology
  • 4
    Colorectal cancer screening – an update
  • 5
    Constant dripping – alcohol and cancer

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.